| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,900 | $30 | $124.8K |
| J0897 | Injection, denosumab, 1 mg | 6,360 | $20 | $114.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 890 | $80 | $73.8K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 8,610 | $10 | $68.9K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,870 | $30 | $48.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,350 | $10 | $47.9K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $150 | $7.9K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 440 | $20 | $7.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $110 | $6.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 70 | $90 | $5.9K |